IP Library Granted Patent US 9,283,307
Granted Patent B2
US 9,283,307 · App. 13/077,857 · Granted Mar 15, 2016

Devices and methods for treatment of damaged tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,283,307
App. No.
13/077,857
Granted
Mar 15, 2016
Kind
B2
Abstract

Methods and devices for treatment of damaged tissue are disclosed, including treatment of wounds by employing non-electrically powered, reduced pressure therapy devices. Maintenance and control of the sub atmospheric pressure exerted may be provided by such devices while minimizing discomfort to the user. The devices may be configured to be worn inconspicuously underneath clothing.

Claims (49)

1. A patient treatment device, comprising a chamber, a conduit with a distal opening and a proximal opening in communication with the chamber, and a conduit sealing member sealing the distal opening; and

a connector configured to connect to the chamber, the connector comprising a first end, a second end, and a connector seal at the second end of the connector, wherein the connector seal comprises a slit seal configuration, and

wherein the second end of the connector is configured to deformably open the conduit sealing member and the conduit is configured to deformably open the connector seal.

2. The patient treatment device of claim 1 , wherein the second end of the connector is configured to retract the conduit sealing member from the distal opening of the conduit.

3. The patient treatment device of claim 1 , wherein the conduit is configured to deform the connector seal into the second end of the connector.

4. The patient treatment device of claim 1 , wherein the conduit sealing member is configured to retract from the distal opening of the conduit along an outer surface of the conduit.

5. The patient treatment device of claim 1 , wherein the conduit is an inner conduit and wherein the device further comprises a chamber conduit attached to the chamber, wherein the inner conduit resides within the chamber conduit.

6. The patient treatment device of claim 5 , wherein the connector seal is configured to seal against the chamber conduit.

7. The patient treatment device of claim 5 , wherein the chamber conduit is configured to receive the second end of the connector.

8. The patient treatment device of claim 7 , wherein the connector is configured to form a mechanical interfit with an outer surface of the chamber conduit.

9. The patient treatment device of claim 8 , wherein the mechanical interfit comprises as least one latch structure.

10. The patient treatment device of claim 9 , wherein the latch structure located on the connector.

11. The patient treatment device of claim 7 , wherein the inner conduit and the chamber conduit are configured to receive the second end of the connector between an inner surface of the chamber conduit and an outer surface of the inner conduit.

12. The patient treatment device of claim 7 , wherein the distal opening of the inner conduit is proximal to a distal opening of the chamber conduit.

13. A patient treatment device, comprising a chamber, a conduit with a distal opening and a proximal opening in communication with the chamber, and a conduit sealing member sealing the distal opening;

a connector configured to connect to the chamber, the connector comprising a first end, a second end, and a connector seal at the second end of the connector; and

a connector housing comprising at least one button member, and

wherein the second end of the connector is configured to deformably open the conduit sealing member and the conduit is configured to deformably open the connector seal.

14. The patient treatment device of claim 1 , wherein the conduit sealing member has a normally closed position.

15. A patient treatment device, comprising a chamber, a conduit with a distal opening and a proximal opening in communication with the chamber, and a conduit sealing member sealing the distal opening, wherein the conduit sealing member comprises a slit seal configuration; and

a connector configured to connect to the chamber, the connector comprising a first end, a second end, and a connector seal at the second end of the connector, and

wherein the second end of the connector is configured to deformably open the conduit sealing member and the conduit is configured to deformably open the connector seal.

16. The patient treatment device of claim 1 , further comprising tubing attached to the first end of the connector.

17. The patient treatment device of claim 13 , wherein the second end of the connector is configured to retract the conduit sealing member from the distal opening of the conduit.

18. The patient treatment device of claim 13 , wherein the conduit is configured to deform the connector seal into the second end of the connector.

19. The patient treatment device of claim 13 , wherein the conduit sealing member is configured to retract from the distal opening of the conduit along an outer surface of the conduit.

20. The patient treatment device of claim 13 , wherein the conduit is an inner conduit and wherein the device further comprises a chamber conduit attached to the chamber, wherein the inner conduit resides within the chamber conduit.

21. The patient treatment device of claim 20 , wherein the connector seal is configured to seal against the chamber conduit.

22. The patient treatment device of claim 20 , wherein the chamber conduit is configured to receive the second end of the connector.

23. The patient treatment device of claim 22 , wherein the connector is configured to form a mechanical interfit with an outer surface of the chamber conduit.

24. The patient treatment device of claim 23 , wherein the mechanical interfit comprises as least one latch structure.

25. The patient treatment device of claim 24 , wherein the latch structure is located on the connector.

26. The patient treatment device of claim 22 , wherein the inner conduit and the chamber conduit are configured to receive the second end of the connector between an inner surface of the chamber conduit and an outer surface of the inner conduit.

27. The patient treatment device of claim 22 , wherein the distal opening of the inner conduit is proximal to a distal opening of the chamber conduit.

28. The patient treatment device of claim 13 , wherein the conduit sealing member has a normally closed position.

29. The patient treatment device of claim 13 , further comprising tubing attached to the first end of the connector.

30. The patient treatment device of claim 15 , wherein the second end of the connector is configured to retract the conduit sealing member from the distal opening of the conduit.

31. The patient treatment device of claim 15 , wherein the conduit is configured to deform the connector seal into the second end of the connector.

32. The patient treatment device of claim 15 , wherein the conduit sealing member is configured to retract from the distal opening of the conduit along an outer surface of the conduit.

33. The patient treatment device of claim 15 , wherein the conduit is an inner conduit and wherein the device further comprises a chamber conduit attached to the chamber, wherein the inner conduit resides within the chamber conduit.

34. The patient treatment device of claim 33 , wherein the connector seal is configured to seal against the chamber conduit.

35. The patient treatment device of claim 33 , wherein the chamber conduit is configured to receive the second end of the connector.

36. The patient treatment device of claim 35 , wherein the connector is configured to form a mechanical interfit with an outer surface of the chamber conduit.

37. The patient treatment device of claim 36 , wherein the mechanical interfit comprises as least one latch structure.

38. The patient treatment device of claim 37 , wherein the latch structure is located on the connector.

39. The patient treatment device of claim 35 , wherein the inner conduit and the chamber conduit are configured to receive the second end of the connector between an inner surface of the chamber conduit and an outer surface of the inner conduit.

40. The patient treatment device of claim 35 , wherein the distal opening of the inner conduit is proximal to a distal opening of the chamber conduit.

41. The patient treatment device of claim 15 , wherein the conduit sealing member has a normally closed position.

42. The patient treatment device of claim 15 , further comprising tubing attached to the first end of the connector.

Assignments (11)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066444/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064730/0636 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2015
From: SPIRACUR INC.
To: KCI LICENSING, INC.
Reel/Frame 037355/0210 →
RELEASE OF SECURITY INTEREST Recorded Dec 1, 2015
From: HEALTHCARE FINANCIAL SOLUTIONS, LLC
To: SPIRACUR INC.
Reel/Frame 037179/0541 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 14, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037111/0836 →
SECURITY INTEREST Recorded Oct 30, 2014
From: SPIRACUR INC., AS GRANTOR
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 034076/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2011
From: HU, DEAN; PINTO, MOSHE; FONG, KENTON
To: SPIRACUR INC.
Reel/Frame 026162/0769 →